Retatrutide 10 mg Peptide (Research Grade)

Key features:

• Tri-agonist profile: GLP-1, GIP, glucagon
• Lyophilised for stability, easy reconstitution
• Suitable for subcutaneous administration in approved research protocols
• Stored refrigerated at 2–8°C after delivery

Suggested reconstitution (research use only)

Reconstitute 10 mg with 2 mL bacteriostatic water to yield 5,000 mcg/mL.
Insulin syringe reference (U-100):
• 1 IU = 50 mcg
• 100 mcg = 2 IU (0.02 mL)
• 500 mcg = 10 IU (0.1 mL)
• 1,000 mcg = 20 IU (0.2 mL)

Typical research scheduling:

Once weekly subcutaneous administration is commonly studied. Many protocols explore 1,000 mcg weekly for 12–24 weeks, with titration considered by some researchers after week 12. Geno X does not recommend or prescribe dosing.

Storage and handling

Keep refrigerated at 2–8°C. Protect from light. Do not freeze. Vials are shipped appropriately and are stable for transit; refrigerate on arrival.

Compliance note

Research compound. Not for human consumption, therapeutic use, or diagnostic procedures. Not TGA-approved.